A dual-modal magnetic nanoparticle probe for preoperative and intraoperative mapping of sentinel lymph nodes by magnetic resonance and near infrared fluorescence imaging

Abstract

The ability to reliably detect sentinel lymph nodes for sentinel lymph node biopsy and lymphadenectomy is important in clinical management of patients with metastatic cancers. However, the traditional sentinel lymph node mapping with visible dyes is limited by the penetration depth of light and fast clearance of the dyes. On the other hand, sentinel lymph node mapping with radionucleotide technique has intrinsically low spatial resolution and does not provide anatomic details in the sentinel lymph node mapping procedure. This work reports the development of a dual modality imaging probe with magnetic resonance and near infrared imaging capabilities for sentinel lymph node mapping using magnetic iron oxide nanoparticles (10 nm core size) conjugated with a near infrared molecule with emission at 830 nm. Accumulation of magnetic iron oxide nanoparticles in sentinel lymph nodes leads to strong T₂ weighted magnetic resonance imaging contrast that can be potentially used for preoperative localization of sentinel lymph nodes, while conjugated near infrared molecules provide optical imaging tracking of lymph nodes with a high signal to background ratio. The new magnetic nanoparticle based dual imaging probe exhibits a significant longer lymph node retention time. Near infrared signals from nanoparticle conjugated near infrared dyes last up to 60 min in sentinel lymph node compared to that of 25 min for the free near infrared dyes in a mouse model. Furthermore, axillary lymph nodes, in addition to sentinel lymph nodes, can be also visualized with this probe, given its slow clearance and sufficient sensitivity. Therefore, this new dual modality imaging probe with the tissue penetration and sensitive detection of sentinel lymph nodes can be applied for preoperative survey of lymph nodes with magnetic resonance imaging and allows intraoperative sentinel lymph node mapping using near infrared optical devices.

Keywords

Sentinel lymph node metastasis nanoparticles near infrared magnetic resonance imaging optic imaging

Get full access to this article

View all access options for this article.

References

Radovanovic

Golubovic

Plzak

. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol 2004; 30(9): 913–917.

Veronesi

Galimberti

Zurrida

. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001; 37(4): 454–458.

Aikou

Kitagawa

Kitajima

. Sentinel lymph node mapping with GI cancer. Cancer Metastasis Rev 2006; 25(2): 269–277.

Frumovitz

Ramirez

Levenback

. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol 2008; 110(3, Suppl. 2): S17–S20.

Roberts

Cochran

. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends. J Surg Oncol 2004; 85(3): 152–161.

Kaleya

Heckman

Most

. Lymphatic mapping and sentinel node biopsy: a surgical perspective. Semin Nucl Med 2005; 35(2): 129–134.

Sakorafas

Peros

. Sentinel lymph node biopsy in breast cancer: what a physician should know, a decade after its introduction in clinical practice. Eur J Cancer Care (Engl) 2007; 16(4): 318–321.

Marchal

Rauch

Morel

. Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes. World J Surg 2006; 30(1): 55–62.

Choi

Kono

Corbeil

. Model to quantify lymph node enhancement on indirect sonographic lymphography. AJR Am J Roentgenol 2004; 183(2): 513–517.

10.

Kobayashi

Kawamoto

Bernardo

. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 2006; 111(3): 343–351.

11.

Suga

Yamamoto

Tangoku

. Breast sentinel lymph node navigation with three-dimensional interstitial multidetector-row computed tomographic lymphography. Invest Radiol 2005; 40(6): 336–342.

12.

Torchia

Nason

Danzinger

. Interstitial MR lymphangiography for the detection of sentinel lymph nodes. J Surg Oncol 2001; 78(3): 151–156. discussion 157.

13.

Zhang

Wang

Xiao

. Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye. Biomaterials 2010; 31(7): 1911–1917.

14.

Rasmussen

Tan

Marshall

. Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 2009; 20(1): 74–82.

15.

Soltesz

Kim

. Sentinel lymph node mapping of the gastrointestinal tract by using invisible light. Ann Surg Oncol 2006; 13(3): 386–396.

16.

Kobayashi

Kawamoto

Star

. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 2003; 63(2): 271–276.

17.

Herborn

Vogt

Lauenstein

. Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: preliminary results in rabbits. J Magn Reson Imaging 2003; 18(3): 328–335.

18.

Koyama

Talanov

Bernardo

. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging 2007; 25(4): 866–871.

19.

Melancon

Wang

Wen

. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping. Invest Radiol 2007; 42(8): 569–578.

20.

Talanov

Regino

Kobayashi

. Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett 2006; 6(7): 1459–1463.

21.

Strekowski

Mason

Lee

. Synthesis of water-soluble near-infrared cyanine dyes functionalized with [(succinimido)oxy]carbonyl group. J Heterocyclic Chem 2003; 40(5): 913–916.

22.

Yang

Mao

Wang

. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 2009; 5(2): 235–243.

23.

Chen

Wang

Yeh

. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Biomaterials 2010; 31(20): 5397–5407.

24.

Chen

Duan

. Biocompatible polysiloxane-containing diblock copolymer PEO-b-PgammaMPS for coating magnetic nanoparticles. ACS Appl Mater Interfaces 2009; 1(10): 2134–2140.

25.

Atkins

. Colorimetric determination of iron in vitamin supplement tablets. A general chemistry experiment. J Chem Educ 1975; 52(8): 550–550.

26.

Duan

Kuang

Wang

. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity. J Phys Chem C 2008; 112(22): 8127–8131.

27.

Nasr

Liu

Hotchandani

. Dye-capped semiconductor nanoclusters. Excited state and photosensitization aspects of rhodamine 6G H-aggregates bound to SiO2 and SnO2 colloids. J Phys Chem-Us 1996; 100(26): 11054–11061.

28.

Frullano

Meade

. Multimodal MRI contrast agents. J Biol Inorg Chem 2007; 12(7): 939–949.

29.

Jennings

Long

. ‘Two is better than one’ – probes for dual-modality molecular imaging. Chem Commun 2009; 24: 3511–3524.

30.

Grobner

. Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl 2006; 21(6): 1745–1745.

31.

Marckmann

Skov

Rossen

. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17(9): 2359–2362.

32.

Nakajima

Takeda

Kobayashi

. Nano-sized fluorescent particles as new tracers for sentinel node detection: experimental model for decision of appropriate size and wavelength. Cancer Sci 2005; 96(6): 353–356.

33.

Kosaka

Ogawa

Sato

. In vivo real-time, multicolor, quantum dot lymphatic imaging. J Invest Dermatol 2009; 129(12): 2818–2822.

34.

Kobayashi

Hama

Koyama

. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett 2007; 7(6): 1711–1716.

35.

Bourrinet

Bengele

Bonnemain

. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Investig Radiol 2006; 41(3): 313–324.

36.

Chouly

Pouliquen

Lucet

. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 1996; 13(3): 245–255.

37.

Rogers

Jung

Lewis

. Use of USPIO-induced magnetic susceptibility artifacts to identity sentinel lymph nodes and lymphatic drainage patterns. I. Dependence of artifact size with subcutaneous Combidex (R) dose in rats. Magn Reson Imaging 1998; 16(8): 917–923.

38.

Zhang

Zhong

Wang

. T(1)-eeighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles. J Magn Reson Imaging 2011; 33(1): 194–202.

39.

Cong

Takeda

Hamanaka

. Uniform silica coated fluorescent nanoparticles: synthetic method, improved light stability and application to visualize lymph network tracer. Plos One 2010; 5(10): e13167–e13167.

40.

Jeon

Kim

Choi

. In vivo imaging of sentinel nodes using fluorescent silica nanoparticles in living mice. Mol Imag Biol 2010; 12(2): 155–162.

41.

Kircher

Mahmood

King

. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003; 63(23): 8122–8125.